ATE553192T1 - Eine dna-zielsequenz von einem xeroderma pigmentosum-gen abspaltende meganukleasevarianten und ihre verwendung - Google Patents

Eine dna-zielsequenz von einem xeroderma pigmentosum-gen abspaltende meganukleasevarianten und ihre verwendung

Info

Publication number
ATE553192T1
ATE553192T1 AT07734243T AT07734243T ATE553192T1 AT E553192 T1 ATE553192 T1 AT E553192T1 AT 07734243 T AT07734243 T AT 07734243T AT 07734243 T AT07734243 T AT 07734243T AT E553192 T1 ATE553192 T1 AT E553192T1
Authority
AT
Austria
Prior art keywords
xeroderma pigmentosum
target sequence
dna target
meganuclease variants
sequence separating
Prior art date
Application number
AT07734243T
Other languages
English (en)
Inventor
Sylvain Arnould
Christophe Perez-Michaut
Julianne Smith
Original Assignee
Cellectis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellectis filed Critical Cellectis
Application granted granted Critical
Publication of ATE553192T1 publication Critical patent/ATE553192T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
AT07734243T 2006-02-13 2007-02-13 Eine dna-zielsequenz von einem xeroderma pigmentosum-gen abspaltende meganukleasevarianten und ihre verwendung ATE553192T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IB2006/000589 WO2007093836A1 (en) 2006-02-13 2006-02-13 Meganuclease variants cleaving a dna target sequence from a xp gene and uses thereof
PCT/IB2007/000924 WO2007093918A2 (en) 2006-02-13 2007-02-13 Meganuclease variants cleaving a dna target sequence from a xeroderma pigmentosum gene and uses thereof

Publications (1)

Publication Number Publication Date
ATE553192T1 true ATE553192T1 (de) 2012-04-15

Family

ID=36579794

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07734243T ATE553192T1 (de) 2006-02-13 2007-02-13 Eine dna-zielsequenz von einem xeroderma pigmentosum-gen abspaltende meganukleasevarianten und ihre verwendung

Country Status (8)

Country Link
US (2) US20090222937A1 (de)
EP (1) EP1989299B1 (de)
JP (1) JP2009526521A (de)
CN (1) CN101384712A (de)
AT (1) ATE553192T1 (de)
AU (1) AU2007216264A1 (de)
CA (1) CA2639149A1 (de)
WO (2) WO2007093836A1 (de)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009095742A1 (en) * 2008-01-31 2009-08-06 Cellectis New i-crei derived single-chain meganuclease and uses thereof
WO2004067753A2 (en) 2003-01-28 2004-08-12 Cellectis Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof.
ES2347684T3 (es) 2005-03-15 2010-11-03 Cellectis Variantes de la meganucleasa i-crei con especificidad modifica, metodo de preparacion y usos de las mismas.
CA2626262C (en) 2005-10-18 2015-09-08 Homme W. Hellinga Rationally-designed meganucleases with altered sequence specificity and dna-binding affinity
WO2007093836A1 (en) * 2006-02-13 2007-08-23 Cellectis Meganuclease variants cleaving a dna target sequence from a xp gene and uses thereof
US8765448B2 (en) 2007-06-05 2014-07-01 Bayer CropScience, N.V. Methods and means for exact replacement of target DNA in eukaryotic organisms
CN101784658A (zh) 2007-06-06 2010-07-21 赛莱克蒂斯公司 增强来自I-CreI的大范围核酸酶的切割活性的方法
WO2009019528A1 (en) * 2007-08-03 2009-02-12 Cellectis Meganuclease variants cleaving a dna target sequence from the human interleukin-2 receptor gamma chain gene and uses thereof
EP3578646A3 (de) 2007-10-31 2020-03-18 Precision Biosciences, Inc. Rational konstruierte einzelketten-meganukleasen mit nicht-palindrom-erkennungssequenzen
WO2009074842A1 (en) * 2007-12-13 2009-06-18 Cellectis Improved chimeric meganuclease enzymes and uses thereof
WO2009114321A2 (en) 2008-03-11 2009-09-17 Precision Biosciencs, Inc. Rationally-designed meganucleases for maize genome engineering
EP3495478A3 (de) 2008-07-14 2019-07-24 Precision Biosciences, Inc. Erkennungssequenzen für meganukleasen aus i-crei und ihre verwendung
CA2736336A1 (en) * 2008-09-08 2010-03-11 Cellectis Meganuclease variants cleaving a dna target sequence from a glutamine synthetase gene and uses thereof
EP2180058A1 (de) 2008-10-23 2010-04-28 Cellectis Meganuklease-Rekombinationssystem
EP2435560A2 (de) 2009-05-26 2012-04-04 Cellectis Megankukleasevarianten zur spaltung des genoms eines pathogenen nicht-integrierenden virus und anwendung
WO2011036510A1 (en) * 2009-09-24 2011-03-31 Cellectis Meganuclease variants cleaving the genome of the herpes simplex virus and uses thereof
WO2011007193A1 (en) 2009-07-17 2011-01-20 Cellectis Viral vectors encoding a dna repair matrix and containing a virion-associated site specific meganuclease for gene targeting
WO2011021062A1 (en) * 2009-08-21 2011-02-24 Cellectis Meganuclease variants cleaving a dna target sequence from the human lysosomal acid alpha-glucosidase gene and uses thereof
WO2011036640A2 (en) 2009-09-24 2011-03-31 Cellectis Meganuclease reagents of uses thereof for treating genetic diseases caused by frame shift/non sense mutations
WO2011064750A1 (en) 2009-11-27 2011-06-03 Basf Plant Science Company Gmbh Chimeric endonucleases and uses thereof
AU2010325549B2 (en) 2009-11-27 2017-04-20 Basf Plant Science Company Gmbh Optimized endonucleases and uses thereof
JP2013511979A (ja) 2009-11-27 2013-04-11 ビーエーエスエフ プラント サイエンス カンパニー ゲーエムベーハー キメラエンドヌクレアーゼおよびその使用
EP2539445B1 (de) * 2010-02-26 2018-03-21 Cellectis Verwendung von endonukleasen für den einsatz von transgenen in safe-harbor-loci
US20130149786A1 (en) * 2010-04-30 2013-06-13 Cellectis I-crei variants with new specificity and methods of their generation
EP2569435A1 (de) 2010-05-12 2013-03-20 Cellectis Eine dna-zielsequenz von einem rhodopsin-gen abspaltende meganukleasevarianten und ihre verwendung
WO2011141820A1 (en) 2010-05-12 2011-11-17 Cellectis Meganuclease variants cleaving a dna target sequence from the dystrophin gene and uses thereof
RU2639512C2 (ru) 2010-06-09 2017-12-21 Байер Кропсайенс Нв Способы и средство модификации растительного генома в нуклеотидной последовательности, широко используемой в геномной инженерии растений
AU2011264074B2 (en) 2010-06-09 2015-01-22 Bayer Cropscience Nv Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering
CA2802822A1 (en) 2010-06-15 2012-01-05 Cellectis Method for improving cleavage of dna by endonuclease sensitive to methylation
SG186932A1 (en) 2010-07-07 2013-02-28 Cellectis Meganucleases variants cleaving a dna target sequence in the nanog gene and uses thereof
WO2012010976A2 (en) 2010-07-15 2012-01-26 Cellectis Meganuclease variants cleaving a dna target sequence in the tert gene and uses thereof
WO2012007848A2 (en) 2010-07-16 2012-01-19 Cellectis Meganuclease variants cleaving a dna target sequence in the was gene and uses thereof
EP2633040B1 (de) 2010-10-27 2019-07-10 Cellectis Verfahren zur erhöhung der wirkung von doppelsträngiger bruchinduzierter mutagenese
US9044492B2 (en) 2011-02-04 2015-06-02 Cellectis Sa Method for modulating the efficiency of double-strand break-induced mutagenesis
WO2012138901A1 (en) 2011-04-05 2012-10-11 Cellectis Sa Method for enhancing rare-cutting endonuclease efficiency and uses thereof
CA3111953C (en) 2011-04-05 2023-10-24 Cellectis Method for the generation of compact tale-nucleases and uses thereof
WO2012158778A1 (en) 2011-05-16 2012-11-22 Cellectis S.A. Doubly secure transgenic algae or cyanobacteria strains to prevent their establishment and spread in natural ecosystems
WO2013009525A1 (en) 2011-07-08 2013-01-17 Cellectis S.A. Method for increasing the efficiency of double-strand break-induced mutagenssis
CN107287234A (zh) 2011-08-22 2017-10-24 拜尔作物科学公司 修饰植物基因组的方法和手段
EP2612918A1 (de) 2012-01-06 2013-07-10 BASF Plant Science Company GmbH In planta-Rekombination
WO2014093622A2 (en) 2012-12-12 2014-06-19 The Broad Institute, Inc. Delivery, engineering and optimization of systems, methods and compositions for sequence manipulation and therapeutic applications
EP3597755A1 (de) 2013-06-17 2020-01-22 The Broad Institute, Inc. Freisetzung, verwendung und therapeutische anwendungen der crispr-cas-systeme und zusammensetzungen zur abzielung auf störungen und erkrankungen mit viralen komponenten
KR20240172759A (ko) 2013-06-17 2024-12-10 더 브로드 인스티튜트, 인코퍼레이티드 간의 표적화 및 치료를 위한 ＣＲＩＳＰＲ­Ｃａｓ 시스템, 벡터 및 조성물의 전달 및 용도
SG11201510327TA (en) 2013-06-17 2016-01-28 Broad Inst Inc Delivery, engineering and optimization of systems, methods and compositions for targeting and modeling diseases and disorders of post mitotic cells
EP3653229A1 (de) 2013-12-12 2020-05-20 The Broad Institute, Inc. Abgabe, verwendung und therapeutische anwendungen der crispr-cas-systeme und zusammensetzungen zur genomeditierung
JP2017501149A (ja) 2013-12-12 2017-01-12 ザ・ブロード・インスティテュート・インコーポレイテッド 粒子送達構成成分を用いた障害及び疾患の標的化のためのｃｒｉｓｐｒ−ｃａｓ系及び組成物の送達、使用及び治療適用
RS61853B1 (sr) 2014-10-29 2021-06-30 Bicyclerd Ltd Biciklični peptidni ligandi specifični za mt1-mmp
EP3889260A1 (de) 2014-12-12 2021-10-06 The Broad Institute, Inc. Geschützte guide-rnas (pgrnas)
EP3230452B1 (de) 2014-12-12 2025-06-11 The Broad Institute, Inc. Deaktivierte guides für crispr-transkriptionsfaktoren
WO2016094874A1 (en) 2014-12-12 2016-06-16 The Broad Institute Inc. Escorted and functionalized guides for crispr-cas systems
WO2016094880A1 (en) 2014-12-12 2016-06-16 The Broad Institute Inc. Delivery, use and therapeutic applications of crispr systems and compositions for genome editing as to hematopoietic stem cells (hscs)
CA2970370A1 (en) 2014-12-24 2016-06-30 Massachusetts Institute Of Technology Crispr having or associated with destabilization domains
WO2016205749A1 (en) 2015-06-18 2016-12-22 The Broad Institute Inc. Novel crispr enzymes and systems
US11730819B2 (en) 2016-12-23 2023-08-22 Bicycletx Limited Peptide derivatives having novel linkage structures
EP3615550A1 (de) * 2017-04-27 2020-03-04 BicycleTx Limited Bicyclische peptidliganden und ihre verwendungen
EP3645549A1 (de) 2017-06-26 2020-05-06 BicycleRD Limited Bicyclische peptidliganden mit nachweisbaren anteilen und deren verwendung
JP7670481B2 (ja) 2017-08-04 2025-04-30 バイスクルテクス・リミテッド Ｃｄ１３７に対して特異的な二環式ペプチドリガンド
KR20200128518A (ko) 2018-02-23 2020-11-13 바이사이클티엑스 리미티드 다량체성 비사이클릭 펩타이드 리간드
US11180531B2 (en) 2018-06-22 2021-11-23 Bicycletx Limited Bicyclic peptide ligands specific for Nectin-4
WO2020041380A1 (en) 2018-08-20 2020-02-27 The Broad Institute, Inc. Methods and compositions for optochemical control of crispr-cas9
GB201820295D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for MT1-MMP
GB201820288D0 (en) 2018-12-13 2019-01-30 Bicycle Tx Ltd Bicycle peptide ligaands specific for MT1-MMP
GB201820325D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for psma
CN113544266A (zh) 2018-12-17 2021-10-22 博德研究所 Crispr相关转座酶系统和其使用方法
WO2020128527A1 (en) 2018-12-21 2020-06-25 Bicyclerd Limited Bicyclic peptide ligands specific for pd-l1
CN113474045A (zh) 2018-12-21 2021-10-01 拜斯科技术开发有限公司 Pd-l1特异性的双环肽配体
GB201900529D0 (en) 2019-01-15 2019-03-06 Bicycletx Ltd Bicyclic peptide ligands specific for CD38
TWI862640B (zh) 2019-07-30 2024-11-21 英商拜西可泰克斯有限公司 異質雙環肽複合物
CA3153197A1 (en) 2019-10-03 2021-04-08 Ryan T. Gill Crispr systems with engineered dual guide nucleic acids
AU2020368539A1 (en) 2019-10-16 2022-04-28 Massachusetts Institute Of Technology Engineered muscle targeting compositions
KR20230074119A (ko) 2020-08-03 2023-05-26 바이사이클티엑스 리미티드 펩타이드 기반 링커
EP4298212A1 (de) 2021-02-25 2024-01-03 Artisan Development Labs, Inc. Zusammensetzungen und verfahren zum targeting, editieren oder modifizieren von genen
EP4419672A2 (de) 2021-06-01 2024-08-28 Artisan Development Labs, Inc. Zusammensetzungen und verfahren zum targeting, editieren oder modifizieren von genen
CA3237482A1 (en) 2021-11-03 2023-05-11 The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone Precise genome editing using retrons
WO2023141602A2 (en) 2022-01-21 2023-07-27 Renagade Therapeutics Management Inc. Engineered retrons and methods of use
US20250388896A1 (en) 2022-03-01 2025-12-25 Celyntra Therapeutics Sa Composition and methods for transgene insertion
WO2024044723A1 (en) 2022-08-25 2024-02-29 Renagade Therapeutics Management Inc. Engineered retrons and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6010908A (en) * 1992-08-21 2000-01-04 The Regents Of The University Of California Gene therapy by small fragment homologous replacement
WO2004067753A2 (en) * 2003-01-28 2004-08-12 Cellectis Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof.
WO2007049095A1 (en) * 2005-10-25 2007-05-03 Cellectis Laglidadg homing endonuclease variants having mutations in two functional subdomains and use thereof
WO2007093836A1 (en) * 2006-02-13 2007-08-23 Cellectis Meganuclease variants cleaving a dna target sequence from a xp gene and uses thereof

Also Published As

Publication number Publication date
WO2007093918A3 (en) 2008-01-24
JP2009526521A (ja) 2009-07-23
WO2007093918A2 (en) 2007-08-23
EP1989299B1 (de) 2012-04-11
WO2007093836A1 (en) 2007-08-23
AU2007216264A1 (en) 2007-08-23
US20130061341A1 (en) 2013-03-07
EP1989299A2 (de) 2008-11-12
US20090222937A1 (en) 2009-09-03
CA2639149A1 (en) 2007-08-23
CN101384712A (zh) 2009-03-11

Similar Documents

Publication Publication Date Title
ATE553192T1 (de) Eine dna-zielsequenz von einem xeroderma pigmentosum-gen abspaltende meganukleasevarianten und ihre verwendung
ATE532857T1 (de) Eine dna-zielsequenz von mäuse-rosa26-lokus abspaltende meganukleasevarianten und ihre verwendung
WO2008010093A3 (en) Meganuclease variants cleaving a dna target sequence from a rag gene and uses thereof
WO2008102274A3 (en) Meganuclease variants cleaving a dna target sequence from the beta-2-microglobulin gene and uses thereof
WO2009019614A3 (en) Meganuclease variants cleaving a dna target sequence from the human interleukin-2 receptor gamma chain gene and uses thereof
WO2007057781A8 (en) Laglidadg homing endonuclease variants having mutations in two functional subdomains and use thereof.
WO2009013622A3 (en) Meganuclease variants cleaving a dna target sequence from the human hemoglobin beta gene and uses thereof
ATE536371T1 (de) Verfahren und zusammensetzungen zur gendeaktivierung
SG142154A1 (en) Methods for genomic analysis
WO2010136981A3 (en) Meganuclease variants cleaving the genome of a pathogenic non-integrating virus and uses thereof
WO2004023092A3 (en) Genetic analysis and authentication
DK1791933T3 (da) Fremgangsmåde til enzymatisk afkogning af olie
WO2010138796A3 (en) Methods for assessment and treatment of depression via utilization of single nucleotide polymorphisms analysis
ATE494370T1 (de) Vektoren auf transposonbasis und verfahren zur integration von nukleinsäuren
GB2489187A (en) Compositions,methods and related uses for cleaving modified DNA
WO2007049156A3 (en) I-CreI HOMING ENDONUCLEASE VARIANTS HAVING NOVEL CLEAVAGE SPECIFICITY AND USE THEREOF
WO2008059382A3 (en) Meganuclease variants cleaving a dna target sequence from the hprt gene and uses thereof
DE60041072D1 (de) Em nachweis
WO2009086215A3 (en) Pathway analysis of cell culture phenotypes and uses thereof
WO2014018601A3 (en) New modular base-specific nucleic acid binding domains from burkholderia rhizoxinica proteins
EP2071022A4 (de) S-adenosylmethionin-synthetase-mutanten, diese codierende dnas und verwendungen der mutanten
EA201070229A1 (ru) Нуклеотидные последовательности msca1, влияющие на мужскую фертильность растений, и способ их применения
WO2006138606A3 (en) Cell signaling genes and related methods
WO2008054514A3 (en) Differential expression profiling analysis of cell culture phenotypes and the uses thereof
WO2008157299A3 (en) Differential expression profiling analysis of cell culture phenotypes and uses thereof